DoubleDragon chairman Edgar Sia II and co-chairman Tony Tan Caktiong at the groundbreaking ceermeony ... [+] of Hotel101-Niseko in Auagust 2023. The company said it has filed an F-4 Registration ...

MANILA, Philippines — DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, began its P10-billion bond offer on Monday following the approval of the Securities ...

In the latest market close, Pacific Biosciences of California (PACB) reached $1.44, with a -1.37% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.72%.

But you want to avoid the really big losses like the plague. So consider, for a moment, the misfortune of Pacific Biosciences of California, Inc. (NASDAQ:PACB) investors who have held the stock ...

MANILA, Philippines — DoubleDragon Corp., the listed property developer owned by Edgar “Injap” Sia II and Tony Tan Caktiong, is bolstering significantly its war chest with capital-raising ...

Pacific Biosciences of California, Inc. has a 12-month low of $1.16 and a 12-month high of $7.50. The firm has a market capitalization of $449.13 million, a PE ratio of -1.12 and a beta of 1.95 ...

MANILA, Philippines — DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, will raise up to P10 billion from the retail debt market within this first quarter ...

But you want to avoid the really big losses like the plague. So consider, for a moment, the misfortune of Pacific Biosciences of California, Inc. (NASDAQ:PACB) investors who have held the stock for ...

Pacific Biosciences of California (PACB) closed the latest trading day at $1.67, indicating a -1.18% change from the previous session's end. This change was narrower than the S&P 500's 1.46% loss ...

In a report released today, Eve Burstein from Bernstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report), with a price target of $3.00. The company’s shares closed ...